Systemic effects of local radiotherapy

The Lancet Oncology

Volumn 10, Issue 7, 2009, Pages 718-726

  Formenti, Silvia C ^a   Demaria, Sandra ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CAPECITABINE; DOXORUBICIN; ECI 301; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANEMIA; BLADDER CARCINOMA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CARCINOGENESIS; CARCINOMA; CELL THERAPY; CLINICAL TRIAL; CYTOTOXICITY; DENDRITIC CELL; DRUG MECHANISM; FATIGUE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOMODULATION; IONIZING RADIATION; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOCYTOPENIA; MICROENVIRONMENT; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INJURY; REVIEW; SARCOMA; SIGNAL DETECTION; SWEAT GLAND CARCINOMA; SYNCOPE; THROMBOCYTOPENIA; THYMUS CANCER; TREATMENT RESPONSE; TUMOR IMMUNITY; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS; BYSTANDER EFFECT; COMBINED MODALITY THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; NEOPLASMS; RODENTIA; SIGNAL TRANSDUCTION;

EID: 67649359533     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70082-8     Document Type: Review

References (74)

1. Steel G.G., McMillan T.J., and Peacock J.H. The 5Rs of radiobiology. Int J Radiat Biol 56 (1989) 1045-1048
2. Prise K.M., Schettino G., Folkard M., and Held K.D. New insights on cell death from radiation exposure. Lancet Oncol 6 (2005) 520-528
3. Stone H.B., Peters L.J., and Milas L. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst 63 (1979) 1229-1235
4. Galluzzi L., Maiuri M.C., Vitale I., et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 14 (2007) 1237-1243
5. Apetoh L., Ghiringhelli F., Tesniere A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13 (2007) 1050-1059
6. Zeh Jr. H., and Lotze M.T. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 28 (2005) 1-9
7. Mole R.J. Whole body irradiation-radiology or medicine?. Br J Radiol 26 (1953) 234-241
8. Nagasawa H., and Little J.B. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res 52 (1992) 6394-6396
9. Hickman A.W., Jaramillo R.J., Lechner J.F., and Johnson N.F. Alpha-particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res 54 (1994) 5797-5800
10. Shao C., Folkard M., Michael B.D., and Prise K.M. Targeted cytoplasmic irradiation induces bystander responses. Proc Natl Acad Sci USA 101 (2004) 13495-13500
11. Chiba S., Saito A., Ogawa S., et al. Transplantation for accidental acute high-dose total body neutron- and gamma-radiation exposure. Bone Marrow Transplant 29 (2002) 935-939
12. Khan M.A., Van Dyk J., Yeung I.W., and Hill R.P. Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers. Radiother Oncol 66 (2003) 95-102
13. Langan A.R., Khan M.A., Yeung I.W., Van Dyk J., and Hill R.P. Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic. Radiother Oncol 79 (2006) 231-238
14. Calveley V.L., Khan M.A., Yeung I.W., Vandyk J., and Hill R.P. Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int J Radiat Biol 81 (2005) 887-899
15. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
16. Barcellos-Hoff M.H., Park C., and Wright E.G. Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer 5 (2005) 867-875
17. Hall E.J. Radiobiology for the radiologist (1994), JB Lippincott, Philadelphia, PA
18. Lorimore S.A., Coates P.J., Scobie G.E., Milne G., and Wright E.G. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?. Oncogene 20 (2001) 7085-7095
19. Lorimore S.A., Chrystal J.A., Robinson J.I., Coates P.J., and Wright E.G. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res 68 (2008) 8122-8126
20. Coates P.J., Rundle J.K., Lorimore S.A., and Wright E.G. Indirect macrophage responses to ionizing radiation: implications for genotype-dependent bystander signaling. Cancer Res 68 (2008) 450-456
21. McBride W.H., Chiang C.-S., Olson J.L., et al. A sense of danger from radiation. Radiat Res 162 (2004) 1-19
22. Allavena P., Sica A., Garlanda C., and Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222 (2008) 155-161
23. Flint-Richter P., and Sadetzki S. Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol 8 (2007) 403-410
24. O'Neill D.W., Adams S., and Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104 (2004) 2235-2246
25. Hall E.J., Brenner D.J., Worgul B., and Smilenov L. Genetic susceptibility to radiation. Adv Space Res 35 (2005) 249-253
26. Wright E.G., and Coates P.J. Untargeted effects of ionizing radiation: implications for radiation pathology. Mutat Res 597 (2006) 119-132
27. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 (2008) 436-444
28. Dunn G.P., Bruce A.T., Ikeda H., Old L.J., and Schreiber R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3 (2002) 991-998
29. Smyth M.J., Godfrey D.I., and Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2 (2001) 293-299
30. Gajewski T.F., Meng Y., Blank C., et al. Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213 (2006) 131-145
31. Marigo I., Dolcetti L., Serafini P., Zanovello P., and Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 222 (2008) 162-179
32. Ahn G.O., and Brown J.M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13 (2008) 193-205
33. Melief C.J. Cancer immunotherapy by dendritic cells. Immunity 29 (2008) 372-383
34. Obeid M., Panaretakis T., Joza N., et al. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 14 (2007) 1848-1850
35. Obeid M., Tesniere A., Ghiringhelli F., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13 (2007) 54-61
36. Chakraborty M., Abrams S.I., Coleman C.N., Camphausen K., Schlom J., and Hodge J.W. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res 64 (2004) 4328-4337
37. Reits E.A., Hodge J.W., Herberts C.A., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203 (2006) 1259-1271
38. Newcomb E.W., Demaria S., Lukyanov Y., et al. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res 12 (2006) 4730-4737
39. Matsumura S., Wang B., Kawashima N., et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 181 (2008) 3099-3107
40. Demaria S., Kawashima N., Yang A.M., et al. Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 11 (2005) 728-734
41. Lugade A.A., Sorensen E.W., Gerber S.A., Moran J.P., Frelinger J.G., and Lord E.M. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J Immunol 180 (2008) 3132-3139
42. Chakraborty M., Abrams S.I., Camphausen K., et al. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 170 (2003) 6338-6347
43. Nesslinger N.J., Sahota R.A., Stone B., et al. Standard treatments induce antigen-specific immune responses in prostate cancer. Clin Cancer Res 13 (2007) 1493-1502
44. Schaue D., Comin-Anduix B., Ribas A., et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res 14 (2008) 4883-4890
45. Fisher B., Gunduz N., Coyle J., Rudock C., and Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 49 (1989) 1996-2001
46. Fisher B., Saffer E., Rudock C., Coyle J., and Gunduz N. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res 49 (1989) 2002-2004
47. Van Essen C.F. Radiation enhancement of metastasis: a review. Clin Exp Metastasis 9 (1991) 77-104
48. Camphausen K., Moses M.A., Beecken W.D., Khan M.K., Folkman J., and O'Reilly M.S. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61 (2001) 2207-2211
49. Biswas S., Guix M., Rinehart C., et al. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 117 (2007) 1305-1313
50. Kaminski J.M., Shinohara E., Summers J.B., Niermann K.J., Morimoto A., and Brousal J. The controversial abscopal effect. Cancer Treat Rev 31 (2005) 159-172
51. Ehlers G., and Fridman M. Abscopal effect of radiation in papillary adenocarcinoma. Br J Radiol 46 (1973) 220-222
52. Rees G.J., and Ross C.M. Abscopal regression following radiotherapy for adenocarcinoma. Br J Radiol 56 (1983) 63-66
53. Antoniades J., Brady L.W., and Lightfoot D.A. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int J Radiat Oncol Biol Phys 2 (1977) 141-147
54. Ohba K., Omagari K., Nakamura T., et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 43 (1998) 575-577
55. Camphausen K., Moses M.A., Menard C., et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 63 (2003) 1990-1993
56. Komarova E.A., Diatchenko L., Rokhlin O.W., et al. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17 (1998) 1089-1096
57. Blanquicett C., Saif M.W., Buchsbaum D.J., et al. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res 11 (2005) 8773-8781
58. Demaria S., Ng B., Devitt M.-L., et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 58 (2004) 862-870
59. Shiraishi K., Ishiwata Y., Nakagawa K., et al. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin Cancer Res 14 (2008) 1159-1166
60. Demaria S., Bhardwaj N., McBride W.H., and Formenti S.C. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 63 (2005) 655-666
61. Gulley J.L., Arlen P.M., Bastian N., et al. Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res 11 (2005) 3353-3362
62. Chi K.H., Liu S.J., Li C.P., et al. Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. J Immunother 28 (2005) 129-135
63. Borrello I., and Pardoll D. GM-CSF-based cellular vaccines: a review of the clinical experience. Cytokine Growth Factor Rev 13 (2002) 185-193
64. Jinushi M., Hodi F.S., and Dranoff G. Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines. Immunol Rev 222 (2008) 287-298
65. Cairo M.S. Review of G-CSF and GM-CSF. Effects on neonatal neutrophil kinetics. Am J Pediatr Hematol Oncol 11 (1989) 238-244
66. Shi Y., Liu C.H., Roberts A.I., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res 16 (2006) 126-133
67. Steinman R.M., and Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int J Cancer 94 (2001) 459-473
68. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
69. Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 188 (2002) 147-154
70. Pinedo H.M., Buter J., Luykx-de Bakker S.A., et al. Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells. Eur J Cancer 39 (2003) 1061-1067
71. Spitler L.E., Grossbard M.L., Ernstoff M.S., et al. Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol 18 (2000) 1614-1621
72. Daud A.I., Mirza N., Lenox B., et al. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. J Clin Oncol 26 (2008) 3235-3241
73. Formenti S.C., Friedman K., Chao K., et al. Abscopal response in irradiated patients: results of a proof of principle trial. Int J Radiat Oncol Biol Phys 72 suppl 1 (2008) S6-S7
74. Wan Y.Y., and Flavell R.A. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol Rev 220 (2007) 199-213